Literature DB >> 16467484

Ethics of medication-free research in schizophrenia.

Donna T Chen1, Jonathan D Moreno.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16467484      PMCID： PMC2632218          DOI： 10.1093/schbul/sbj049

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN： 0586-7614            Impact factor:   9.306


× No keyword cloud information.
  7 in total

1.  The ethics of placebo-controlled trials--a middle ground.

Authors:  E J Emanuel; F G Miller
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

2.  Consensus and controversy in clinical research ethics.

Authors:  Baruch A Brody; Laurence B McCullough; Richard R Sharp
Journal:  JAMA       Date:  2005-09-21       Impact factor: 56.272

3.  Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis.

Authors:  Georg Kemmler; Martina Hummer; Christian Widschwendter; W Wolfgang Fleischhacker
Journal:  Arch Gen Psychiatry       Date:  2005-12

Review 4.  Emerging empirical evidence on the ethics of schizophrenia research.

Authors:  Laura B Dunn; Philip J Candilis; Laura Weiss Roberts
Journal:  Schizophr Bull       Date:  2005-10-19       Impact factor: 9.306

Review 5.  Medication-free research in early episode schizophrenia: evidence of long-term harm?

Authors:  John R Bola
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

Review 6.  Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.

Authors:  Scott W Woods; Ralitza V Gueorguieva; C Bruce Baker; Robert W Makuch
Journal:  Arch Gen Psychiatry       Date:  2005-09

Review 7.  The rationale and ethics of medication-free research in schizophrenia.

Authors:  W T Carpenter; N R Schooler; J M Kane
Journal:  Arch Gen Psychiatry       Date:  1997-05
  7 in total
  2 in total

1.  "We Need to Deploy Them Very Thoughtfully and Carefully": Perceptions of Analytical Treatment Interruptions in HIV Cure Research in the United States-A Qualitative Inquiry.

Authors:  Karine Dubé; David Evans; Lynda Dee; Laurie Sylla; Jeff Taylor; Asheley Skinner; Bryan J Weiner; Sandra B Greene; Stuart Rennie; Joseph D Tucker
Journal:  AIDS Res Hum Retroviruses       Date:  2017-07-10       Impact factor: 2.205

Review 2.  The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics.

Authors:  Marc De Hert; Jan Sermon; Paul Geerts; Kristof Vansteelandt; Joseph Peuskens; Johan Detraux
Journal:  CNS Drugs       Date:  2015-08       Impact factor: 5.749
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.